| Authors: |
Roos K; RIA Medicinal Chemistry, AstraZeneca, Pepparedsleden 1, 431 83, Mölndal, Sweden. katarina.roos@gmail.com., Hogner A; CVMD Medicinal Chemistry, AstraZeneca, Pepparedsleden 1, 431 83, Mölndal, Sweden., Ogg D; Discovery Sciences, AstraZeneca, Alderley Park, Macclesfield, Cheshire, SK10 4TF, UK., Packer MJ; Oncology Medicinal Chemistry, AstraZeneca, Alderley Park, Macclesfield, Cheshire, SK10 4TF, UK., Hansson E; Discovery Sciences, AstraZeneca, Pepparedsleden 1, 431 83, Mölndal, Sweden., Granberg KL; CVMD Medicinal Chemistry, AstraZeneca, Pepparedsleden 1, 431 83, Mölndal, Sweden., Evertsson E; RIA Medicinal Chemistry, AstraZeneca, Pepparedsleden 1, 431 83, Mölndal, Sweden., Nordqvist A; CVMD Medicinal Chemistry, AstraZeneca, Pepparedsleden 1, 431 83, Mölndal, Sweden. anneli.nordqvist@astrazeneca.com. |